SPERO THERAPEUTICS INC (SPRO)
US84833T1034 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 18.26M 95.71% | 53.51M 193.04% | 103.781M 93.95% | 37.683M -63.69% | 20.4M -45.86% | 6.375M -68.75% | 36.312M 469.60% | 70.278M 93.54% | 93.687M 33.31% | 101.64M 8.49% | 83.028M -18.31% | |
| EBITDA YoY % growth | -87.32M -11.45% | -29.7M 65.99% | 27.154M 191.43% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -87.97M -11.20% | -30.57M 65.25% | 26.787M 187.63% | -75.492M -381.82% | -60.384M 20.01% | -25.755M 57.35% | -102K 99.60% | 38.403M 37,750.00% | 53.805M 40.11% | 66.198M 23.03% | 46.512M -29.74% | |
| Operating Margin | -481.76% | -57.13% | 25.81% | -200.34% | -296.00% | -404.00% | -0.28% | 54.64% | 57.43% | 65.13% | 56.02% | |
| EPS YoY % growth | -2.89 19.27% | -1.66 42.56% | 0.52 131.33% | -1.08 -307.92% | -0.73 32.31% | -0.45 38.68% | -0.02 96.59% | 0.55 3,700.00% | 0.76 37.96% | 0.90 18.12% | 0.64 -28.98% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.37 -138.25% | -0.19 19.25% | -0.17 49.00% | -0.15 53.78% | -0.04 88.89% |
| Revenue Q2Q % growth | 3.06M -95.84% | 4.59M -50.47% | 4.59M -54.99% | 5.1M -62.14% | 12.75M 316.67% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -20.91M -141.38% | -35.088M -150.95% | -37.128M -94.79% | -38.76M -108.47% | -40.392M -93.17% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.32 -900.00% | -0.37 | 0.05 | 13.65% |
| Q2 2024 Q2Q % growth | -0.33 -43.48% | -0.39 | 0.06 | 14.86% |
| Q1 2024 Q2Q % growth | -0.24 4.00% | -0.04 | -0.20 | -443.03% |
| Q4 2023 Q2Q % growth | 0.96 74.55% | -0.10 | 1.06 | 1,041.18% |
| Q3 2023 Q2Q % growth | 0.04 112.12% | -0.03 | 0.07 | 230.72% |
| Q2 2023 Q2Q % growth | -0.23 73.56% | -0.35 | 0.12 | 34.32% |
| Q1 2023 Q2Q % growth | -0.25 75.25% | -0.34 | 0.09 | 26.47% |
| Q4 2022 Q2Q % growth | 0.55 161.11% | 0.04 | 0.51 | 1,144.44% |
| Q3 2022 Q2Q % growth | -0.33 52.86% | -0.31 | -0.02 | -6.66% |
| Q2 2022 Q2Q % growth | -0.87 -38.10% | -0.95 | 0.08 | 7.96% |
| Q1 2022 Q2Q % growth | -1.01 -53.03% | -0.89 | -0.12 | -13.90% |
| Q4 2021 Q2Q % growth | -0.90 -32.35% | -0.76 | -0.14 | -18.04% |
| Q3 2021 Q2Q % growth | -0.70 18.60% | -0.68 | -0.02 | -3.46% |
| Q2 2021 Q2Q % growth | -0.63 25.88% | -0.77 | 0.14 | 17.76% |
| Q1 2021 Q2Q % growth | -0.66 44.54% | -0.66 | 0.00 | -0.32% |
| Q4 2020 Q2Q % growth | -0.68 48.48% | -0.76 | 0.08 | 10.25% |
| Q3 2020 Q2Q % growth | -0.86 9.47% | -0.89 | 0.03 | 3.24% |
| Q2 2020 Q2Q % growth | -0.85 -14.86% | -1.15 | 0.30 | 25.79% |
| Q1 2020 Q2Q % growth | -1.19 -310.34% | -1.28 | 0.08 | 6.67% |
| Q4 2019 Q2Q % growth | -1.32 | -1.10 | -0.22 | -19.64% |
| Q3 2019 Q2Q % growth | -0.95 | -0.86 | -0.09 | -9.92% |
| Q2 2019 Q2Q % growth | -0.74 | -0.66 | -0.08 | -11.61% |
| Q1 2019 Q2Q % growth | -0.29 | -0.80 | 0.51 | 63.67% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 13.469M -47.12% | 7.82M | 5.649M | 72.24% |
| Q2 2024 Q2Q % growth | 10.197M 275.44% | 3.332M | 6.865M | 206.03% |
| Q1 2024 Q2Q % growth | 9.267M 347.90% | 21.964M | -12.697M | -57.81% |
| Q4 2023 Q2Q % growth | 73.524M 54.98% | 19.006M | 54.518M | 286.85% |
| Q3 2023 Q2Q % growth | 25.473M 1,167.31% | 15.266M | 10.207M | 66.86% |
| Q2 2023 Q2Q % growth | 2.716M 36.48% | 1.097M | 1.619M | 147.58% |
| Q1 2023 Q2Q % growth | 2.069M -0.05% | 1.02M | 1.049M | 102.84% |
| Q4 2022 Q2Q % growth | 47.44M 1,631.39% | 23.324M | 24.116M | 103.40% |
| Q3 2022 Q2Q % growth | 2.01M -34.31% | 5.525M | -3.515M | -63.62% |
| Q2 2022 Q2Q % growth | 1.99M -61.36% | 1.173M | 817K | 69.65% |
| Q1 2022 Q2Q % growth | 2.07M -71.64% | 2.618M | -548K | -20.93% |
| Q4 2021 Q2Q % growth | 2.74M 43.46% | 5.049M | -2.309M | -45.73% |
| Q3 2021 Q2Q % growth | 3.06M -23.50% | 4.556M | -1.496M | -32.84% |
| Q2 2021 Q2Q % growth | 5.15M 197.69% | 4.616M | 534K | 11.57% |
| Q1 2021 Q2Q % growth | 7.3M 329.41% | 3.223M | 4.077M | 126.50% |
| Q4 2020 Q2Q % growth | 1.91M -47.38% | 3.745M | -1.835M | -49.00% |
| Q3 2020 Q2Q % growth | 4M -13.79% | 3.265M | 735K | 22.51% |
| Q2 2020 Q2Q % growth | 1.73M -19.91% | 3.471M | -1.741M | -50.16% |
| Q1 2020 Q2Q % growth | 1.7M -77.98% | 3.511M | -1.811M | -51.58% |
| Q4 2019 Q2Q % growth | 3.63M | 3.991M | -361K | -9.05% |
| Q3 2019 Q2Q % growth | 4.64M | 2.502M | 2.138M | 85.45% |
| Q2 2019 Q2Q % growth | 2.16M | 5.151M | -2.991M | -58.07% |
| Q1 2019 Q2Q % growth | 7.72M | 1.921M | 5.799M | 301.87% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 6.09% | -6.8% | 20.45% |
| Revenue | 0% | -56.52% | 7.02% | 90.93% |